Hewlett Packard Enterprise insider files Form 4 for 30,000-share sale
Rhea-AI Filing Summary
Hewlett Packard Enterprise Co. (HPE) – Form 4 insider transaction
Executive Vice President & GM of Intelligent Edge, Philip J. Mottram, reported a single open-market sale of HPE common stock executed on 26 June 2025 (trade date 25 June 2025 is shown in Table I). The transaction was carried out under a previously adopted Rule 10b5-1 trading plan dated 26 March 2025.
- Shares sold: 30,000 common shares
- Sale price: approximately $18.50 per share (per Table I)
- Estimated gross proceeds: c.$555,000
- Direct holdings after sale: 72,427 common shares
- Derivative holdings: a total of ~277,749 restricted stock units (RSUs) across three previously disclosed grants; dividend-equivalent rights were credited on 16 Jan 2025 and 18 Apr 2025.
The RSU positions comprise:
- 49,325.0063 units from the Dec 2022 grant (final vesting Dec 2025)
- 107,745.9327 units from the Dec 2023 grant (vesting through Dec 2026)
- 120,678.5687 units from the Dec 2024 grant (vesting through Dec 2027)
No option exercises, purchases, or other equity transactions were reported, and there is no indication of earnings-related information in this filing.
Key takeaways for investors: The sale represents roughly 29% of Mottram’s directly held common stock before the trade, but he maintains a substantial equity interest through both direct shares and unvested RSUs. Because the transaction was executed under a pre-arranged 10b5-1 plan, it may carry less signalling weight than an unsolicited discretionary sale.
Positive
- Transaction executed under a Rule 10b5-1 plan, indicating pre-arranged, governance-aligned trading.
- Executive retains 72,427 common shares and ~277,749 RSUs, maintaining substantial equity alignment with shareholders.
Negative
- Sale of 30,000 shares (~29% of direct holdings) could be perceived as reduced confidence, though mitigated by 10b5-1 context.
Insights
TL;DR Routine 10b5-1 sale of 30k shares; executive still holds significant equity—signal neutral.
The 30,000-share sale equates to roughly 0.002% of HPE’s ~1.3 bn share count, and less than one-third of Mottram’s direct stake. While insider selling can flag concerns, execution under a 10b5-1 plan and the retention of over 72 k shares plus nearly 278 k RSUs suggest the sale is primarily for liquidity or diversification. No new options were exercised and no purchases were made, so dilution is unaffected. From a valuation standpoint, the dollar value (<$1 m) is immaterial to HPE’s market cap and does not alter the investment thesis.
TL;DR Governance-friendly: pre-planned trade, transparent disclosure; modest insider selling.
Use of a Rule 10b5-1 plan aligns with best-practice governance, reducing allegations of opportunistic trading. The filing provides clear footnotes on RSU accruals and dividend equivalents, enhancing disclosure quality. Post-transaction ownership indicates continued alignment between the executive and shareholders through sizeable unvested equity. Therefore, governance impact is neutral-to-positive, with limited risk implications.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 30,000 | $18.50 | $555K |
| Grant/Award | Restricted Stock Units | 651.0063 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Units | 1,461.9327 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Units | 1,682.5687 | $0.00 | $0.00 |
Footnotes (4)
- F1. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.
- F2. As previously reported, on 12/08/22, the reporting person was granted 138,122 restricted stock units ("RSUs"), 46,040 of which vested on 12/08/23, 46,041 of which vested on 12/08/24, and 46,041 of which will vest on 12/08/25. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 reflects 255.6741 dividend equivalent rights at $23.41 per RSU credited to the reporting person's account on 01/16/25, and 395.3322 dividend equivalent rights at $15.14 per RSU credited to the reporting person's account on 04/18/25.
- F3. As previously reported, on 12/07/23, the reporting person was granted 155,087 RSUs, 51,695 of which vested on 12/07/24 and 51,696 of which will vest on each of 12/07/25 and 12/07/26. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 reflects 574.1546 dividend equivalent rights at $23.41 per RSU credited to the reporting person's account on 01/16/25, and 887.7781 dividend equivalent rights at $15.14 per RSU credited to the reporting person's account on 04/18/25.
- F4. As previously reported, on 12/09/24, the reporting person was granted 118,996 RSUs, 39,665 of which will vest on 12/09/25 and 12/09/26, and 39,666 of which will vest on 12/09/27. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 reflects 660.8065 dividend equivalent rights at $23.41 per RSU credited to the reporting person's account on 01/16/25, and 1,021.7622 dividend equivalent rights at $15.14 per RSU credited to the reporting person's account on 04/18/25.
AI-generated analysis. How Rhea-AI works. Not financial advice.